M K Proteins Limited Stock Price Today (NSE: MKPL)

M K Proteins Limited

4.07+0.04 (+0.99%)
Market Closed

Fundamental Score

...

M K Proteins Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

M K Proteins Limited share price today is 4.07, up +0.99% on NSE/BSE as of 17 September 2026. M K Proteins Limited (MKPL) is a Small-cap company in the Edible Oil sector with a market capitalisation of 152.78 (Cr). The 52-week high for MKPL share price is 8.85 and the 52-week low is 3.56. At a P/E ratio of 31.31x, MKPL is currently trading above its industry average P/E of 19.45x. The company has a Return on Equity (ROE) of 9.37% and a debt-to-equity ratio of 0.47.

M K Proteins Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
4.25
Low
3.92
Volume
87.8K
Change
-3.82%

M K Proteins Limited share price chart: -3.82% return over the past month. 52-week high ₹8.85, 52-week low ₹3.56.

M K Proteins Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
4.054.203.994.071.25L (Cr)
4.004.703.934.031.29L (Cr)
3.974.003.903.9284.27K (Cr)
4.014.053.683.961.21L (Cr)
4.034.064.004.0179.30K (Cr)
4.054.054.004.0367.49K (Cr)
4.044.063.983.9993.48K (Cr)
4.024.074.004.0373.51K (Cr)
4.064.123.924.021.44L (Cr)
4.024.074.004.0641.79K (Cr)

M K Proteins Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
4.174.703.684.07-2.40%
4.164.324.004.11-1.20%
4.864.954.054.18-13.99%
5.105.154.584.71-7.65%
5.315.404.685.04-5.08%
4.065.804.055.31+30.79%
5.015.793.563.87-22.75%
5.675.754.515.08-10.41%
6.146.504.525.48-10.75%
6.276.355.636.07-3.19%
6.816.926.006.29-7.64%
6.727.495.556.81+1.34%

Returns & Performance

Poor

Return on Equity (ROE)

9.37%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

14.97%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

5.27%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

M K Proteins Limited Valuation Check

Poor

Price to Earnings (P/E)

31.31x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

19.45x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

74.82%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-60.65%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

0.19%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

4.24%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-8.01%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-7.99%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Average

Debt to Equity Ratio

0.47x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

6.07x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-5.87 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

M K Proteins Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of MKPL across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Strong Interest Coverage (6.07x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Healthy Liquidity Position (Current Ratio: 2.25)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Balanced Promoter Holding (74.82%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

7 factors identified

Below-Average Return on Equity (9.37%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Profit Decline Concern (-60.65%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Limited Growth History (4.24% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Earnings Growth (-8.01% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-7.99% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Negative Free Cash Flow (₹-5.87 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

M K Proteins Limited vs Edible Oil Peers

Peer Comparison - Edible Oil

Compare M K Proteins Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
23.4/100
4
₹152.78
31.3
Average
9.37%
Poor
14.97%
Average
0.5
Excellent
-7.99%
Poor
4.24%
Average
0.00%
61.7/100
814
₹105807.00
55.8
Average
43.05%
Excellent
39.32%
Excellent
0.1
Excellent
8.50%
Good
11.08%
Good
0.47%
68.1/100
341
₹37096.69
18.8
Average
0.00%
Poor
12.08%
Average
0.2
Excellent
24.26%
Excellent
19.74%
Excellent
1.01%
54.5/100
188
₹24223.83
21.0
Average
10.49%
Average
18.00%
Good
0.1
Excellent
7.77%
Good
15.04%
Excellent
0.53%
56.4/100
231
₹6803.53
13.0
Average
30.10%
Excellent
40.80%
Excellent
0.4
Excellent
53.33%
Excellent
23.48%
Excellent
0.00%
50.3/100
1338
₹3744.65
0.07%
Poor
7.66%
Poor
0.7
Good
143.34%
Excellent
53.12%
Excellent
0.00%
31.7/100
668
₹2518.74
90.3
Average
1.43%
Poor
1.85%
Poor
0.0
Excellent
-7.79%
Poor
11.66%
Good
0.00%
64.5/100
507
₹1120.34
21.8
Average
33.66%
Excellent
35.08%
Excellent
2.4
Poor
61.19%
Excellent
32.53%
Excellent
0.27%
26.3/100
198
₹495.52
15.9
Average
8.61%
Poor
14.83%
Average
0.1
Excellent
4.35%
Average
7.15%
Good
0.00%
69.9/100
82
₹411.10
12.3
Average
15.38%
Good
20.11%
Excellent
0.0
Excellent
17.70%
Excellent
5.96%
Good
0.38%
47.2/100
643
₹224.17
11.6
Average
5.56%
Poor
8.58%
Poor
0.2
Excellent
-21.97%
Poor
2.71%
Average
0.00%

M K Proteins Limited PE Ratio History

Historical price-to-earnings ratio for MKPL — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20250.22₹6.0727.6x
FY 20240.30₹8.1427.1x
FY 20230.29₹28.0296.6x
FY 20220.27₹24.8991.7x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

M K Proteins Limited Quarterly Performance

Latest quarterly metrics for MKPL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

0.19%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-60.65%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

4.24%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-7.99%

Compounded annual net profit growth over 5 years

M K Proteins Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for MKPL — calculated from daily price history

37RSI 14
Neutral — RSI 37

Momentum is balanced — neither overbought nor oversold.

SMA 50
4
▼ Price below SMA 50 — Short-term bearish
SMA 200
5
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
92K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

M K Proteins Limited Financial Statements

Annual income statement, balance sheet and cash flow for M K Proteins Limited (MKPL) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for M K Proteins Limited

Loading latest quarterly results...

About MKPL (M K Proteins Limited)

M K Proteins Ltd is a dynamic and forward-thinking edible oil company deeply rooted in the Indian agricultural landscape. Specializing in the refining and trading of a diverse port...folio of vegetable oils, MKPL is committed to providing high-quality, nutritious products for both domestic and international markets. Sourcing premium raw materials, MKPL's portfolio encompasses a wide range of refined oils, including rice bran, sunflower, cottonseed, soybean, palm, canola, and rice bran bleached oils, each carefully processed to retain its natural goodness and distinct flavor profile. Driven by a passion for excellence and a commitment to sustainable practices, MKPL continuously strives to meet the evolving needs of its customers and contribute to a healthier future for consumers. Beyond its core refining activities, M K Proteins Ltd actively manages the valuable by-products generated during the oil extraction process. This includes the processing and marketing of rice bran fatty acid oils, rice bran waxes, gums, and spent earth, demonstrating a commitment to resource optimization and waste reduction. Moreover, MKPL engages in the import, processing, and distribution of crude oils, further solidifying its position as a key player in the edible oil industry. Through strategic partnerships and a robust supply chain, the company ensures a consistent and reliable supply of high-quality oils to meet the growing demand from various sectors. Established in 2012 and headquartered in Ambala, India, M K Proteins Ltd has quickly established itself as a reputable and reliable name in the edible oil market. The company's success is built on a foundation of integrity, innovation, and a relentless pursuit of customer satisfaction. With a dedicated team of experienced professionals and state-of-the-art facilities, MKPL is well-positioned to continue its growth trajectory and expand its presence in the dynamic world of edible oils. Focusing on quality, sustainability, and customer-centricity, M K Proteins Ltd is poised to remain a prominent force in the Indian and global edible oil market for years to come.

Company Details

Symbol:MKPL
Industry:Edible Oil
Sector:Edible Oil

Key Leadership

Mr. Parmod Kumar
MD & Executive Director
Mr. Vinod Kumar
CFO & Whole Time Director
Ms. Neha Aggarwal
Company Secretary & Compliance Officer

MKPL Share Price: Frequently Asked Questions

What is the current share price of M K Proteins Limited?

M K Proteins Limited (MKPL) trades at ₹4.07 on NSE and BSE. Market cap ₹152.78 (Cr). Educational data only.

What is the P/E ratio of M K Proteins Limited?

M K Proteins Limited has a P/E of 31.31x vs industry average 19.45x.

What is the Bull Run score for M K Proteins Limited?

M K Proteins Limited has a Bull Run score of 23.4/100 based on 25+ financial parameters.

Does M K Proteins Limited pay dividends?

M K Proteins Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of M K Proteins Limited?

M K Proteins Limited has ROE of 9.37%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of M K Proteins Limited?

M K Proteins Limited has debt-to-equity of 0.47.

Is M K Proteins Limited a good investment?

Bull Run gives M K Proteins Limited a score of 23.4/100. This is not investment advice — consult a SEBI-registered advisor.